Abstract
Vitamin A and its biologically active derivatives, retinal and retinoic acid (RA), together with a large repertoire of synthetic analogues are collectively referred to as retinoids. Naturally occurring retinoids regulate the growth and differentiation of a wide variety of cell types and play a crucial role in the physiology of vision and as morphogenic agents during embryonic development. Retinoids and their analogues have been evaluated as chemoprevention agents, and also in the management of acute promyelocytic leukaemia. Retinoids exert most of their effects by binding to specific receptors and modulating gene expression. The development of new active retinoids and the identification of two distinct families of retinoid receptors has led to an increased understanding of the cellular effects of activation of these receptors. In this article we review the use of retinoids in chemoprevention strategies, discuss the cellular consequences of activated retinoid receptors, and speculate on how our increasing understanding of retinoid-induced signalling pathways may contribute to future therapeutic strategies in the management of malignant disease.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Allenby, G., Bocquel, M-T, Saunders, M., Kazmer, S., Speck, J., Rosenberger, M., Lovey, A., Kastner, P., Grippo, J. F., Chambon, P. & Levin, A. A. (1993) Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90: 30–34.
Anzano, M. A., Byers, S. W., Smith, J. M., Peer, C. W., Mullen, L. T., Brown, C. C., Roberts, A. B. & Sporn, M. B. (1994) Prevention of breast cancer in the rat with 9-cis retinoic acid as a single agent and in combination with tamoxifen. Cancer Res 54: 4614–4617.
Arnold, A., Ayoub, J., Douglas, L., Hoogendoorn, P., Skingley, L., Gelmon, K., Hirsh, V. & Eisenhauer, E. (1994) Phase II trial of 13-cis retinoic acid and interferon α in non-small cell lung cancer. J Natl Cancer Inst 86: 306–309.
Atencia, R., Garcia-Sanz, M., Unda, F. & Arechaga, J. (1994) Apoptosis during retinoic acid-induced differentiation of F9 embryonal carcinoma cells. Exp Cell Res 214: 663–667.
Bavinck, J. N., Tieben, L. M., van der Woude, F. J., Tegzess, A. M., Hermans, J., Schegget, J. & Vermeer, B-J (1995) Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 13: 1933–1938.
Benner, S. E., Pajak, T. F., Lippman, S. M., Earley, C. & Hong, W. K. (1994) Prevention of second primary tumours with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst 86: 140–141.
Bertram, J. S. (1983) Inhibition of neoplastic transformation in vitro by retinoids. Cancer Surv 2: 243–262.
Bolla, M., Lefur, R., Ton Van, J., Domenge, C., Badet, J. M., Koskas, Y. & Laplanche, A. (1994) Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentre double-blind randomised study. Eur J Cancer 30A: 767–772.
Bollag, W., Majewski, S. & Jablonska, S. (1994) Cancer combination chemotherapy with retinoids: experimental rationale. Leukemia 8: S11–S15.
Caliaro, M. J., Vitaux, P., Lafon, C., Lochon, I., Nehme, A., Valette, A., Canal, P., Bugat, R. & Jozan, S. (1997) Multifactional mechanism of the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines. Br J Cancer 75: 333–340.
Castaigne, S., Chomienne, C., Daniel, M. T., Ballerini, P., Berger, R., Fenaux, P. & Degos, L. (1990) All-trans retinoic acid as differentiation therapy for acute promyelocytic leukaemia. Clinical Results. Blood 76: 1704–1709.
Chambon, P. (1995) The molecular and genetic dissection of the retinoid signalling pathway. Rec Prog Horm Res 50: 317–332.
Chen, J. D. & Evans, R. M. (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454–457.
Chen, J. Y., Clifford, J., Zusi, C., Starrett, J., Tortolani, D., Ostrowski, J., Reczek, P. R., Chambon, P. & Gronemeyer, H. (1996) Two distinct actions of retinoid-receptor ligands. Nature 382: 819–822.
Chen, Z., Zue, Y., Zhang, R., Tao, R., Xia, X., Li, C., Wang, W., Zu, W., Yao, X. & Ling, B. (1991) A clinical and experimental study on all trans retinoic acid treated acute promyelocytic leukaemia patients. Blood 78: 1413–1419.
Chiesa, F., Tradati, N., Marazza, M., Rossi, N., Boracchi, P., Mariani, L., Formelli, E., Giardini, R., Costa, A., De Palo, G. & Veronesi, U. (1993) Fenretinide (4HPR) in chemoprevention of oral leukoplakia. J Cell Biochem 17F: 255–261.
Colston, K. W., Mackay, A. G., James, S. Y., Binderup, L., Chander, S. K. & Coombes, R. C. (1992) EB1089: a new vitamin D analog that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmcol 44: 2273–2280.
Costa, A., Formelli, F., Chiesa, F., Decensi, A., DePalo, G. & Veronesi, U. (1994) Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res 54: 2032s–2037s.
Costa, A., De Palo, G., Decensi, A., Formelli, F., Chiesa, F., Nava, M., Camerini, T., Marubini, E. & Veronesi, U. (1995) Retinoids in cancer chemoprevention. Ann NY Acad Sci 768: 148–162.
Creek, K. E., Jenkins, G. R., Khan, M. A., Batova, A., Hodam, J. R., Tolleson, W. H. & Pirisi, L. (1994) Retinoic acid suppresses human papillomavirus type 16 (HPV16)-mediated transformation of human keratinocytes and inhibits the expression of the HPV16 oncogenes. Adv Exp Med Biol 354: 19–35.
Darwiche, N., Scita, G., Jones, C., Rutberg, S., Greenwald, E., Tennenbaum, T., Collins, S. J., DeLuca, L. M. & Yuspa, S. H. (1996) Loss of retinoic acid receptors in mouse skin tumours is associated with activation of the rasHa oncogene and high risk for premalignant progression. Cancer Res 56: 4942–4949.
De Bruijn, D. R., Oerlemans, F., Hendricks, W., Baats, E., Ploemacker, R., Wieringa, B. & Geurts van Kessel, A. (1994) Normal development, growth and reproduction in cellular retinoic acid binding proteins-1 (CRABP1) null mutant mice. Differentiation 58: 141–148.
De Luca, L. M., Darwiche, N., Celli, G., Kosa, K., Jones, C., Ross, S. & Chen, L. C. (1994) Vitamin A in epithelial differentiation and skin carcinogenesis. Nutr Rev 52: 45–52.
Dey, A., Minucci, S. & Ozato, K. (1994) Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo. Mol Cell Biol 14: 8191–8201.
Dhingra, K., Papadopoulous, N., Lippman, S., Lotan, R. & Legha, S. S. (1993) Phase II study of alpha-interferon and 13-cis retinoic acid in metastatic melanoma. Invest New Drugs 11: 39–43.
Durand, B., Saunders, M., Leroy, P., Leid, M. & Chambon, P. (1992) All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR–RXR heterodimers bound to DR1 and DR1 repeated motifs. Cell 71: 73–85.
Edwards, L. & Jaffe, P. (1990) The effects of topical tretinoin on dysplastic nevi. Arch Dermatol 126: 494–499.
Eisenhauer, E. A., Lippman, S. M., Kavanagh, J. J., Parades-Espinoza, M., Arnold, A., Hong, W. K., Massimini, G., Schleuniger, U., Bollag, W., Holdener, E. E. & Krakoff, I. (1994) Combination 13-cis retinoic acid and interferon α-2a in the therapy of solid tumours. Leukaemia 8: S38–S41.
Elstner, E., Linker-Israeli, M., Umiel, T., Le, J., Grillier, I., Said, J., Shintaku, I. P., Krajewski, S., Reed, J. C., Binderup, L. & Koeffler, H. P. (1996) Combination of a potent 20-epi-vitamin D3 analogue (KH1060) with 9-cis retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukaemic cells. Cancer Res 56: 3570–3576.
Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889–895.
Evans, R. M. & Hollenberg, S. M. (1988) Zinc fingers: gilt by association. Cell 52: 1–3.
Fan, S., El-Deiry, W. S., Bae, I., Freeman, J., Jondle, D., Bhatia, K., Fornace, A. J. Jr, Magrath, I., Kohn, K. W. & O’Connor, P. M. (1994) p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824–5830.
Fanjul, A. N., Bouterfa, H., Dawson, M. & Pfahl, M. (1996) Potential role for retinoic acid receptor-γ in the inhibition of breast cancer cells by selective retinoids and interferons. Cancer Res 56: 1571–1577.
Fenaux, P., Castaigne, S., Dombret, H., Archimbaud, E., Duarte, M., Morel, P., Lamy, T., Tilly, H., Guerci, A., Maloisel, F., Bordessoule, D., Sadoun, A., Tiberghien, P., Fegueux, N., Daniel, M. T., Chomienne, C. & Degos, L. (1992) All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukamia: a pilot study on 26 cases. Blood 80: 2176–2181.
Fontana, J. A. (1987) Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp Cell Biol 55: 136–144.
Fontana, J. A., Miranda, D. & Burrows-Mezu, A. (1990) Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a Mr39,000 protein. Cancer Res 50: 1977–1982.
Frankel, S. R., Eardley, A., Heller, G., Berman, E., Miller, W. H., Dmitrovsky, E. & Warrell, R. P. (1994) All-trans retinoic acid for acute promyelocytic leukaemia. Ann Intern Med 120: 278–286.
Freedman, L. P. (1992) Anatomy of the steroid receptor zinc finger region. Endocr Rev 13: 129–145.
Gianni, M., Terao, M., Fortino, I., LiCalzi, M., Viggiano, V., Barbui, T., Rambaldi, A. & Garratini, E. (1997) Stat I is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Blood 89: 1001–1012.
Giguere, V., Ong, E. S., Segui, P. & Evans, R. M. (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330: 624–629.
Giguere, V. (1994) Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signalling. Endocr Rev 15: 61–79.
Gorry, P., Lufkin, T., Dierich, A., Rochette-Eghy, C., Decimo, D., Dolle, P., Mark, M., Durand, B. & Chambon, P. (1994) The cellular retinoic acid binding protein I is dispensable. Proc Natl Acad Sci USA 91: 9032–9036.
Gottardis, M. M., Bischoff, E. D., Shirley, M. A., Wagoner, M. A., Lamph, W. W. & Heyman, R. A. 1996a) Chemoprevention of mammary carcinoma by LGD1069 (targretin): an RXR-selective ligand. Cancer Res 56: 5566–5570.
Gottardis, M. M., Lamph, W. W., Shalinsky, D. R., Wellstein, A. & Heyman, R. A. 1996b) The efficacy of 9-cis retinoic acid in experimental models of cancer. Breast Cancer Res Treat 38: 85–96.
Gucev, Z. S., Oh, Y., Kelley, K. M. & Rosenfeld, R. G. (1996) Insulin-like growth factor binding protein-3 mediates retinoic-acid and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res 56: 1545–1550.
Guchelaar, H. J., Timmer-Bosscha, H., Dam-Meiring, A., Uges, D. R. A., Oosterhuis, J. W., de Vries, E. G. E. & Mulder, N. H. (1993) Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic acid induced cellular differentiation of a murine embryonal carcinoma cell line. Int J Cancer 55: 442–447.
Hallum, A. V., Alberts, D. S., Lippman, S. M., Inclan, L., Shamdas, G. J., Childers, J. M., Surwit, E. A., Modiano, M. & Hatch, K. D. (1995) Phase II study of 13-cis retinoic acid plus interferon-α2A for heavily pre-treated squamous carcinoma of the cervix. Gynecol Oncol 56: 382–386.
Halpern, A. C., Schuchter, L. M., Elder, D. E., Guerry, D., Elenitsas, R., Trock, B. & Matozzo, I. (1994) Effects of topical tretinoin on dysplastic nevi. J Clin Oncol 12: 1028–1035.
Han, J. (1993) Highlights of the cancer chemoprevention studies in China. Prev Med 22: 712–722.
Harant, H., Korschineck, I., Krupitza, G., Fazeny, B., Dittrich, C. & Grunt, T. W. (1993) Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reactions following reverse transcription. Br J Cancer 68: 530–536.
Higashimoto, Y., Ohata, M., Nishio, K., Iwamoto, Y., Fujimoto, H., Uetani, K., Suruda, T., Nakamura, Y., Funasako, M. & Saijo, N. (1996) 1α,25-dihydroxyvitamin D3 and all-trans retinoic acid inhibit the growth of a lung cancer cell line. Anticancer Res 16: 2653–2659.
Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, G., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P. & Strong, S. (1986) 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315: 1501–1515.
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. S., Kramer, A. M., Lotan, R., Peters, L. L., Dimery, I. W., Brown, B. W. & Goepfert, H. (1990) Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 323: 795–801.
Hong, W. K. & Itri, L. M. (1994). Retinoids and human cancer. In: The Retinoids. Sporn MS, Roberts AB and Goodman DS (Eds), pp 597–658. Raven Press: New York
Horwitz, K. B., Jackson, T. A., Rain, D. L., Richer, J. K., Takimoto, G. S. & Tung, L. (1996) Nuclear hormone receptor co-activators and co-repressors. Mol Endocrinol 10: 1167–1177.
Huang, M., Ye, Y., Chen, S., Chai, J., Lu, J., Zhao, L., Gu, L. & Wang, Z. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukaemia. Blood 72: 567–572.
Kalemkerian, G. P., Slusher, R., Ramalingam, S., Gadgeel, S. & Mabry, M. (1995) Growth inhibition and induction of apoptosis by fenretinide in small cell lung cancer cell lines. J Natl Cancer Inst 87: 1674–1680.
Kanamaru, A., Takemoto, Y., Tanimoto, M., Murakami, H., Asou, N., Kobayashi, T., Kuriyama, K., Ohmoto, E., Sakamaki, H., Tsubaki, K., Hiraoka, A., Yamada, O., Oh, H., Saito, K., Matsuda, S., Minato, K., Ueda, T. & Ohno, R. (1995) All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukaemia. Blood 85: 1202–1206.
Kliewer, S. A., Umesono, K., Mangelsdorf, D. J. & Evans, R. M. (1992) Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355: 446–449.
Kolla, V., Lindner, D. J., Weihua, X., Borden, E. C. & Kalvakolanu, D. V. (1996) Modulation of interferon-inducible gene expression by retinoic acid. J Biol Chem 271: 10508–10514.
Kondo, S., Barna, B. P., Kondo, Y., Tanaka, Y., Casey, G., Liu, J., Morimura, T., Kaakaji, R., Peterson, J. W., Werbel, B. & Barnett, G. H. (1996) WAFI/CIPI increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. Oncogene 13: 1279–1285.
Kurokawa, R., Soderstrom, M., Horlein, A., Halachmi, S., Brown, M., Rosenfeld, M. G. & Glass, C. K. (1995) Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377: 451–454.
Laudet, V., Hanni, C., Coll, J., Catzeflis, F. & Stehelin, D. (1992) Evolution of the nuclear receptor gene superfamily. EMBO J 11: 1003–1013.
Le Ruppert, K. I., Masters, J. R. W., Kneuchel, R., Seegers, S., Tainsky, M. A., Hofstaedter, F. & Buettner, R. (1992) The effect of retinoic acid on chemosensitivity of PA-1 human teratocarcinoma cells and its modulation by an activated N-ras oncogene. Int J Cancer 51: 646–651.
Lee, J. S., Lippman, S. M., Benner, S. E., Lee, J. J., Ro, J. Y., Lukeman, J. M., Morice, R. C., Peters, E. J., Pang, A. C., Fritsche, H. A. Jr & Hong, W. K. (1994) Randomised placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 12: 937–945.
Lee, P. P. H., Lee, M-T, Darcy, K. M., Shudo, K. & Ip, M. M. (1995) Modulation of normal mammary epithelial cell proliferation, morphogenesis and functional differentiation by retinoids: a comparison of the retinobenzoic acid derviative RE80 with retinoic acid. Endocrinology 136: 1707–1717.
Liebermann, D. A., Hoffman, B. & Steinman, R. A. (1995) Molecular controls of growth arrest and apoptosis – p53-dependent and independent pathways. Oncogene 11: 199–210.
Lippman, S. M., Batsakis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H. & Hong, W. K. (1993) Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 328: 15–20.
Lippman, S. M., Clayman, G. L., Huber, M. H., Benner, S. E. & Hong, W. K. (1995) Biology and reversal of aerodigestive tract carcinogenesis. Cancer Treat Res 74: 89–115.
Liu, M., Iavarone, A. & Freedman, L. P. (1996) Transcriptional activation of the human p21 WAFI/CIFI gene by retinoic acid receptor. J Biol Chem 271: 31723–31728.
Lotan, R. (1994) Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res 54: 1987s–1990s.
Lotan, R. (1995). Cellular biology of the retinoids. In Retinoids in Oncology, Degos L and Parkinson DR (eds), pp. 27–42. Springer: Berlin
Lotan, R. (1996) Retinoids in cancer chemoprevention. FASEB J 10: 1031–1039.
Lowe, S. W., Ruley, H. E., Jacks, T. & Housman, D. E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957–967.
Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E. & Jacks, T. (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266: 807–810.
Mader, S., Leroy, P., Chen, J. Y. & Chambon, P. (1993) Multiple parameters control the selectivity of nuclear receptors for their response elements. J Biol Chem 268: 591–600.
Mangelsdorf, D. J., Umesono, K., Kliewer, S. A., Borgmeyer, U., Ong, E. S. & Evans, M. (1991) A direct repeat in the cellular retinol binding protein type II gene confers differential regulation by RXR and RAR. Cell 66: 555–561.
Mangelsdorf, D. J., Borgmeyer, U., Heyman, R. A., Zhou, J. Y., Ong, E. S., Oro, A. E., Kakizuka, A. & Evans, R. M. (1992) Characterisation of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6: 329–344.
Marth, C., Daxenbichler, G. & Dapunt, O. (1986) Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells. J Natl Cancer Inst 77: 1197–1202.
Martin, S. J., Bradley, J. G. & Cotter, T. G. (1990) HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 79: 448–453.
Matikainen, S., Ronni, T., Hurme, M., Pine, R. & Julkunen, I. (1996) Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 88: 114–123.
Meyskens, F. L., Surwit, E., Moon, T. E., Childers, J. M., Davis, J. R., Dorr, R. T., Johnson, C. S. & Alberts, D. S. (1994) Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all trans retinoic acid a randomised trial. J Natl Cancer Inst 86: 539–543.
Miller, G. J., Stapleton, G. E., Ferrara, J. A., Lucia, M. S., Pfister, S., Hedlund, T. E. & Upadhya, P. (1992) The human prostatic carcinoma cell line LNCaP expresses biologically active specific receptors for 1,25-dihydroxyvitamin D3. Cancer Res 52: 515–520.
Miller, V. A., Benedetti, F. M., Rigas, J. R., Verret, A. L., Pfister, D. G., Straus, D., Kris, M. G., Crisp, M., Heyman, R., Loewen, G. R., Truglia, J. A. & Warrell, R. P. (1997) Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J Clin Oncol 15: 790–795.
Moasser, M. M., DeBlasio, A. & Dmitrovsky, E. (1994) Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor γ in human teratocarcinomas. Oncogene 9: 833–840.
Moon, R. C., Mehta, R. G. & Rao, KJVN (1994). Retinoids and cancer in experimental animals. In The Retinoids, Sporn MB, Roberts AB and Goodman DS (eds), pp. 573–595. Raven Press: New York
Moon, T. E., Levine, N., Cartmel, B. & Bangert, J. (1997) Retinoids in prevention of skin cancer. Cancer Lett 114: 203–205.
Nagpal, S., Saunders, M., Kastner, P., Durand, B., Nakshatri, H. & Chambon, P. (1992) Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70: 1007–1019.
Nagy, L., Thomazy, V. A., Shipley, G. L., Fesus, L., Lamph, W., Heyman, R. A., Chandraratna, R. A. S. & Davies, P. J. A. (1995) Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 15: 3540–3551.
Ohno, R., Yoshida, H., Fukutani, H., Naoe, T., Ohshima, T., Kyo, T., Endoh, N., Fujimoto, T., Kobayashi, T., Hiraoka, A., Mizoguchi, H., Kodera, Y., Suzuki, H., Hirano, M., Akiyama, H., Aoki, N., Shindo, H. & Yokomaku, S. (1993) Multi-institutional study of all trans retinoic acid as a differentiation therapy of refractory acute promyelocytic leukaemia. Leukaemia 7: 1722–1727.
Oridate, N., Lotan, D., Xu, X-C, Hong, W. K. & Lotan, R. (1996) Differential induction of apoptosis by all-trans retinoic acid and N-(4-hydroxyphenyl) retinamide in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2: 855–863.
Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Pirket, P., Rosementz, N., Clerici, M., Soresi, E., Valente, M., Belloni, P. A. & Ravasi, G. (1993) Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 11: 1216–1222.
Perlmann, T. & Evans, R. M. (1997) Nuclear receptors in Sicily: all in the famiglia. Cell 90: 391–397.
Petkovich, M., Brand, N. J., Krust, A. & Chambon, P. (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330: 444–450.
Piacentini, M., Annicchiarico-Petruzzelli, M., Oliverio, S., Piredda, L., Biedler, J. L. & Melino, G. (1992) Phenotype-specific tissue transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int J Cancer 52: 271–278.
Pratt, M. A. C., Deonarine, D., Teixeira, C., Novosad, D., Tate, B. F. & Grippo, J. F. (1996) The AF-2 region of the retinoic-acid receptor α mediates retinoic acid inhibition of estrogen receptor function in breast cancer cells. J Biol Chem 271: 20346–20352.
Prout, G. R. Jr & Barton, B. A. (1992) 13-cis retinoic acid in chemoprevention of superficial bladder cancer. J Cell Biochem S16I: 148–152.
Reichel, R., Koeffler, H. P. & Norman, A. W. (1989) The role of the vitamin D endocrine system in health and disease. N Engl J Med 320: 980–991.
Rinaldi, D. A., Lippman, S. M., Burris, H. A., Chou, C., von Hoff, D. D. & Hong, W. K. (1993) Phase II study of 13-cis retinoic acid and interferon α 2a in patients with advanced squamous cell lung cancer. Anti-cancer Drugs 4: 33–36.
Rishi, A. K., Gerald, T. M., Shao, Z. M., Li, X-S, Baumann, R. G., Dawson, M. I. & Fontana, J. A. (1996) Regulation of the human retinoic acid receptor α gene in the estrogen receptor negative human breast carcinoma cell lines SK BR-3 and MDA-MB-435. Cancer Res 56: 5246–5252.
Roberts, A. B. & Sporn, M. B. (1992) Mechanistic interrelationships between two superfamilies: the steroid/retinoid receptors and transforming growth factor β. Cancer Surv 14: 205–220.
Roman, S. D., Ormandy, C. J., Manning, D. L., Blamey, R. W., Nicholson, R. I., Sutherland, R. L. & Clarke, C. L. (1993) Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res 53: 5940–5945.
Rook, A. H., Jaworsky, C., Nguyen, T., Grossman, R. A., Wolfe, J. T., Witmer, W. K. & Kligman, A. M. (1995) Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 59: 714–719.
Rubin, M., Fenig, E., Rosenauer, A., Menendez-Botet, C., Achkar, C., Bentel, J. M., Yahalom, J., Mendelsohn, J. & Miller, W. H. Jr (1994) 9-cis retinoic acid inhibits growth of breast cancer cells and down-regulation estrogen receptor RNA and protein. Cancer Res 54: 6549–6556.
Sacks, P. G., Harris, D. & Chou, T. C. (1995) Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: a rationale for combination therapy with chemotherapeutic agents. Int J Cancer 61: 409–415.
Schadendorf, D., Worm, M., Jurgovsky, K., Dippel, E., Michel, S., Charpentier, B., Bernardon, J-M, Reichert, U. & Czarnetzki, B. M. (1994) Retinoic acid receptor γ selective retinoids exert antiproliferative effects on human melanoma cell growth in vitro. Int J Oncol 5: 1325–1331.
Schadendorf, D., Kern, M. A., Artuc, M., Pahl, H. L., Rosenbach, T., Fichtner, I., Nurnberg, W., Stuting, S., Stebut, E., Worm, M., Makki, A., Jurgovsky, K., Kolde, G. & Henz, B. M. (1996) Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro and causes growth inhibition in xenografts in vivo. J Cell Biol 135: 1889–1898.
Scita, G., Darwiche, N., Greenwald, E., Rosenberg, M., Politi, K. & DeLuca, L. M. (1996) Retinoic acid downregulation of fibronectin and retinoic acid receptor α proteins in NIH-3T3 cells: block of this response by ras transformation. J Biol Chem 271: 6502–6508.
Selvakumaran, M., Lin, H-K, Sjin, R. T. T., Reed, J. C., Liebermann, D. A. & Hoffman, B. (1994) The novel primary response gene MyD118 and the proto-oncogenes myb, myc and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukaemia cells. Mol Cell Biol 14: 2352–2360.
Shabahang, M., Buras, R. R., Davoodi, F., Shumaker, L. M., Nauta, R. J., Uskokovic, M. R., Brenner, R. V. & Evans, S. R. T. (1994) Growth inhibition of HT-29 human colon cancer cells by analogs of 1,25-dihydroxyvitamin D3. Cancer Res 54: 4057–4064.
Shalinksy, D. R., Bischoff, E. D., Gregory, M. L., Lamph, W. W., Heyman, R. A., Hayes, J. S., Thomazy, V. & Davies, P. J. A. (1996) Enhanced antitumour efficacy of cisplatin in combination with ALRT 1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice. Clin Cancer Res 2: 511–520.
Shalinsky, D. R., Bischoff, E. D., Lamph, W. W., Zhang, L., Boehm, M. F., Davies, P. J. A., Nadzan, A. M. & Heyman, R. A. (1997) A novel retinoic acid receptor-selective retinoid ALRT1550, has potent antitumour activity against human oral squamous carcinoma xenografts in nude mice. Cancer Res 57: 162–168.
Shao, Z-M, Dawson, M. I., Li, X. S., Rishi, A. K., Sheikh, M. S., Han, Q-X, Ordonez, J. V., Shroot, B. & Fontana, J. A. (1995) p53-independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11: 493–504.
Sheikh, M. S., Shao, Z. M., Li, X-S, Dawson, M., Jetten, A. M., Wu, S., Conley, B. A., Garcia, M., Rochefort, H. & Fontana, J. A. (1994) Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor α acquire sensitivity to growth inhibition by retinoids. J Biol Chem 269: 21440–21447.
Sheikh, M. S., Shao, Z-M, Li, X-S, Ordonez, J. V., Conley, B. A., Wu, S., Dawson, M. I., Han, Q-X, Chao, W., Quick, T., Niles, R. N. & Fontana, J. A. (1995) N-(4-hydroxyphenyl) retinamide (4HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogen 16: 2477–2486.
Smith, W. C., Nakshatri, H., Leroy, P., Rees, J. & Chambon, P. (1991) A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter. EMBO J 10: 2223–2230.
Studer, U. E., Jenzer, S., Biedermann, C., Chollet, D., Kraft, R., Vontoggenburg, H. & Vonbank, F. (1995) Adjuvant treatment with vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumours – final analysis of a prospective randomised multicentre trial in Switzerland. Eur Urol 28: 284–290.
Supino, R., Crosti, M., Clerici, M., Warlters, A., Cleris, L., Zunino, F. & Formelli, F. (1996) Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int J Cancer 65: 491–497.
Symonds, H., Krall, L., Remington, L., Saenz-Robels, M., Lowe, S., Jacks, T. & Van Dyke, T. (1994) p53-dependent apoptosis suppresses tumour growth and progression in vivo. Cell 78: 703–711.
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M. & Wiernik, P. H. (1997) All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med 337: 1021–1028.
Thiruvengadam, R., Atiba, J. O. & Azawi, S. H. (1996) A phase II trial of differentiating agents (tRA) with cisplatin-VP-16 chemotherapy in advanced non-small cell lung cancer. Invest New Drugs 14: 395–401.
Tsang, N-M, Nagasawa, H., Li, C. & Little, J. B. (1995) Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene 10: 2403–2408.
Van der Burg, B., Van der Leede, B. M., Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S. W. & Van der Saag, P. T. (1993) Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 91: 149–157.
Voravud, N., Lippman, S. M., Weber, R. S., Rodriguez, G. I., Yee, D., Dimery, I. W., Earley, C. L., von Hoff, D. D. & Hong, W. K. (1993) Phase II trial of 13-cis retinoic acid plus interferon-α in recurrent head and neck cancer. Invest New Drugs 11: 57–60.
Warrell, R. P., Frankel, S. R., Miller, W. H., Sheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M. S. & Dmitrovsky, E. (1991) Differentiation therapy of acute promyelocytic leukaemia with tretinoin (all-trans retinoic acid). N Engl J Med 324: 1385–1393.
Widschwendter, M., Daxenbichler, G., Dapunt, O. & Marth, C. (1995) Effects of retinoic acid and γ-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells. Cancer Res 55: 2135–2139.
Wilcken, N. R. C., Musgrove, E. A. & Sutherland, R. L. (1997) Different points of action of retinoids and anti-estrogen in G1 phase identified in synchronised T-47D breast cancer cells. Int J Cancer 70: 291–296.
Wu, G. S. & El-Deiry, W. S. (1996) Apoptotic death of tumour cells correlates with chemosensitivity independent of p53 or bcl-2. Clin Cancer Res 2: 623–633.
Yang, N., Schule, R., Mangelsdorf, D. J. & Evans, R. M. (1991) Characterisation of DNA binding and retinoic acid binding properties of retinoic acid receptor. Proc Natl Acad Sci USA 88: 3559–3563.
Zhang, X-K, Hoffmann, B., Tran, PB-V, Graupner, G. & Pfahl, M. (1992) Retinoid X receptor is an auxillary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441–446.
Zugmaier, G., Jager, R., Grage, B., Gottardis, M. M., Havemann, K. & Knabbe, C. (1996) Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer 73: 1341–1346.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Evans, T., Kaye, S. Retinoids: present role and future potential. Br J Cancer 80, 1–8 (1999). https://doi.org/10.1038/sj.bjc.6690312
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690312
Keywords
This article is cited by
-
Nuclear receptors in podocyte biology and glomerular disease
Nature Reviews Nephrology (2021)
-
A new regulatory mechanism for Raf kinase activation, retinoic acid-bound Crabp1
Scientific Reports (2019)
-
Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients
Scientific Reports (2015)
-
Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
BMC Cancer (2014)
-
Retinoic acid has different effects on UCP1 expression in mouse and human adipocytes
BMC Cell Biology (2013)
